System Changes to Ensure Patient Safety and Access to Innovative Devices.
- Published in:
- MD Conference Express, 2013, p. 32, doi. 10.1177/155989771319017
- By:
- Publication type:
- Article
Works matching IS 15598977 AND DT 2013
Results: 189
1
2
Trials to Evaluate CEA Versus CAS in Carotid Artery Stenosis.
- Published in:
- MD Conference Express, 2013, p. 32
- By:
- Publication type:
- Article
3
Hypercholesteremia, Hypertension, and Antiplatelet Therapy in PAD.
- Published in:
- MD Conference Express, 2013, p. 31
- By:
- Publication type:
- Article
4
Device Therapy Approaches for Advanced Heart Failure.
- Published in:
- MD Conference Express, 2013, p. 30, doi. 10.1177/155989771319014
- By:
- Publication type:
- Article
5
Risk of Major Cardiovascular or Cerebrovascular Events After PCI or CABG Increased in Diabetes Mellitus Patients Receiving Insulin.
- Published in:
- MD Conference Express, 2013, p. 24
- By:
- Publication type:
- Article
6
Advances in Endovascular Interventions Will Continue to Improve Patients' Lives.
- Published in:
- MD Conference Express, 2013, p. 14, doi. 10.1177/155989771319001
- By:
- Publication type:
- Article
7
Untitled.
- Published in:
- MD Conference Express, 2013, p. 12
- By:
- Publication type:
- Article
8
No Change in Thrombotic Risk With Short-Term DAPT After Stenting.
- Published in:
- MD Conference Express, 2013, p. 21, doi. 10.1177/155989771319007
- By:
- Publication type:
- Article
9
SORT-OUT VI: Zotarolimus-Eluting Stent Noninferior to Biolimus- Eluting Stent.
- Published in:
- MD Conference Express, 2013, p. 17, doi. 10.1177/155989771319003
- By:
- Publication type:
- Article
10
Next Generation Stents and Scaffolds: Differences in Vascular Response?
- Published in:
- MD Conference Express, 2013, p. 28, doi. 10.1177/155989771319013
- By:
- Publication type:
- Article
11
Renal Denervation and Renal Stenting Are Beginning to Show Benefits in Hypertension and Other Conditions.
- Published in:
- MD Conference Express, 2013, p. 26, doi. 10.1177/155989771319012
- By:
- Publication type:
- Article
12
Thrombectomy Does Not Prevent Microvascular Obstruction in Patients Undergoing PCI for NSTEMI.
- Published in:
- MD Conference Express, 2013, p. 24
- By:
- Publication type:
- Article
13
All-Cause Mortality and Major Stroke Significantly Reduced With Iliofemoral CoreValve Replacement.
- Published in:
- MD Conference Express, 2013, p. 16, doi. 10.1177/155989771319002
- By:
- Publication type:
- Article
14
Prolonged DAPT Is Unnecessary Post-Stenting in Patients Who Are Event-Free at 1 Year.
- Published in:
- MD Conference Express, 2013, p. 23, doi. 10.1177/155989771319009
- By:
- Publication type:
- Article
15
Third-Generation ZES Matches EES in Efficacy and Safety, Without Evidence of Longitudinal Deformation in an All-Corner Population.
- Published in:
- MD Conference Express, 2013, p. 22
- By:
- Publication type:
- Article
16
Tryton Two-Stent Strategy Safe, but Did Not Meet Noninferiority Endpoint.
- Published in:
- MD Conference Express, 2013, p. 20, doi. 10.1177/155989771319006
- By:
- Publication type:
- Article
17
Similar Outcomes With Two-Stent and Provisional Stenting Techniques in Large Side Branch Bifurcation Lesions.
- Published in:
- MD Conference Express, 2013, p. 19, doi. 10.1177/155989771319005
- By:
- Publication type:
- Article
18
Prehospital Bivalirudin Improved Outcomes Versus Heparin in Patients With Myocardial Infarction.
- Published in:
- MD Conference Express, 2013, p. 18, doi. 10.1177/155989771319004
- By:
- Publication type:
- Article
19
New Basal Insulins: The Longer the Better?
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 37, doi. 10.1177/155989771317025
- By:
- Publication type:
- Article
20
Managing Dysglycemia in Diabetic Patients with Heart Failure.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 36, doi. 10.1177/155989771317024
- By:
- Publication type:
- Article
21
Bariatric Surgery in Type 2 Diabetes.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 34, doi. 10.1177/155989771317023
- By:
- Publication type:
- Article
22
Safety Still a Problem in Advanced Technology in Diabetes Care.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 32, doi. 10.1177/155989771317022
- By:
- Publication type:
- Article
23
GLP-1 Based Therapies: Potential for Drug - Disease Interaction.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 30, doi. 10.1177/155989771317021
- By:
- Publication type:
- Article
24
Should We Worry about Raised Triglycerides?
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 29, doi. 10.1177/155989771317020
- By:
- Publication type:
- Article
25
Benefits of DPP-4 Inhibitors in Patients with Type 2 Diabetes and Cardiovascular Risk.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 27, doi. 10.1177/155989771317019
- By:
- Publication type:
- Article
26
Initial Triple Therapy Superior to Stepwise Add-On Therapy in Newly Diagnosed Type 2 Diabetes.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 26, doi. 10.1177/155989771317018
- By:
- Publication type:
- Article
27
New Insulin Glargine Formulation Associated with Less Nocturnal Hypoglycemia.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 25, doi. 10.1177/155989771317017
- By:
- Publication type:
- Article
28
Glycemic Improvement with Canagliflozin is Durable in T2DM Patients on Metformin.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 24, doi. 10.1177/155989771317016
- By:
- Publication type:
- Article
29
Fixed-Ratio Combination of Insulin Degludec and Liraglutide Improves Glycemic Control in Type 2 Diabetes.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 23, doi. 10.1177/155989771317015
- By:
- Publication type:
- Article
30
Type 1 Diabetes Impairs Education and Employment.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 12, doi. 10.1177/155989771317008
- By:
- Publication type:
- Article
31
Trough DPP-4 Inhibition Differs between the Approved DPP-4 Inhibitors.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 22, doi. 10.1177/155989771317014
- By:
- Publication type:
- Article
32
ENDURE: Alogliptin Effective and Safe through 2 Years.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 22, doi. 10.1177/155989771317013
- By:
- Publication type:
- Article
33
Liraglutide is a Safe and Beneficial Adjunct to Insulin in Glycemic Control in Type 1 Diabetes.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 9, doi. 10.1177/155989771317005
- By:
- Publication type:
- Article
34
LEADER Study: Testing the Cardiovascular Safety of Liraglutide.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 14, doi. 10.1177/155989771317011
- By:
- Publication type:
- Article
35
Long-Term Ranibizumab Effective in Diabetic Macular Edema.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 13, doi. 10.1177/155989771317009
- By:
- Publication type:
- Article
36
Cardiovascular Safety of Linagliptin Demonstrated in Pooled Analysis.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 15, doi. 10.1177/155989771317012
- By:
- Publication type:
- Article
37
Left Ventricular Remodeling Reduced with Olmesartan in ROADMAP.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 13, doi. 10.1177/155989771317010
- By:
- Publication type:
- Article
38
Once-Weekly Dulaglutide Produces Superior Glycemic Control Compared with Metformin.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 11, doi. 10.1177/155989771317007
- By:
- Publication type:
- Article
39
Albiglutide Superior to Sitagliptin and Glimepiride in T2DM.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 11, doi. 10.1177/155989771317006
- By:
- Publication type:
- Article
40
Recurrent Venous Thrombosis.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 22, doi. 10.1177/155989771313011
- By:
- Publication type:
- Article
41
Apixaban is an Effective Replacement for Conventional Anticoagulation Therapy.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 11, doi. 10.1177/155989771313004
- By:
- Publication type:
- Article
42
Changes in Management of Atrial Fibrillation since 2010 ESC Guidelines Update.
- Published in:
- MD Conference Express, 2013, v. 13, n. 12, p. 20, doi. 10.1177/155989771312010
- By:
- Publication type:
- Article
43
Improved Treatment of Type 2 Diabetes: Results from the 4B Trial.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 8, doi. 10.1177/155989771317003
- By:
- Publication type:
- Article
44
Review and Update of the United Kingdom Prospective Diabetes Study Trials.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 4, doi. 10.1177/155989771317001
- By:
- Publication type:
- Article
45
Once-Weekly Exenatide Allows Sustained HbA1C Control.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 9, doi. 10.1177/155989771317004
- By:
- Publication type:
- Article
46
Anticoagulant Treatment Requires Special Care in the Elderly.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 30, doi. 10.1177/155989771313016
- By:
- Publication type:
- Article
47
Psychosocial Issues in Diabetes.
- Published in:
- MD Conference Express, 2013, v. 13, n. 17, p. 6, doi. 10.1177/155989771317002
- By:
- Publication type:
- Article
48
Changing Paradigms regarding New Antiplatelet Therapy.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 24, doi. 10.1177/155989771313012
- By:
- Publication type:
- Article
49
Anticoagulation for Isolated Distal Deep Vein Thrombosis May Reduce Serious Complications.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 10, doi. 10.1177/155989771313003
- By:
- Publication type:
- Article
50
Phenotyping and Genotyping of Platelet Disorders.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 29, doi. 10.1177/155989771313015
- By:
- Publication type:
- Article